Amphetamines - Revision history

Rossdonaldson1: /* Background */

2020-11-26T22:01:02Z

Background

2019-09-06T03:47:14Z

Clinical Features

← Revisión anterior		Revisión del 03:47 6 sep 2019
Línea 25:		Línea 25:

	==Clinical Features==		==Clinical Features==
			[[File:Suspectedmethmouth09-19-05.jpg\|thumb\|Meth mouth]]
	{\| class="wikitable"		{\| class="wikitable"
	\|-		\|-

2019-09-06T03:46:27Z

Background

← Revisión anterior		Revisión del 03:46 6 sep 2019
Línea 4:		Línea 4:
	[[File:Mescaline.png\|thumbnail\|Mescaline]]		[[File:Mescaline.png\|thumbnail\|Mescaline]]
	[[File:Desoxyn (methamphetamine) 5 mg tablets.jpg\|thumb\|Desoxyn tablets – pharmaceutical methamphetamine hydrochloride]]		[[File:Desoxyn (methamphetamine) 5 mg tablets.jpg\|thumb\|Desoxyn tablets – pharmaceutical methamphetamine hydrochloride]]
			[[File:Blue Crystal Meth.jpg\|thumb\|Crystal meth – illicit methamphetamine hydrochloride]]
	*Class of xenobiotics (Substituted amphetamines) based on a common central structure (ethylamine group attached to a phenol ring)		*Class of xenobiotics (Substituted amphetamines) based on a common central structure (ethylamine group attached to a phenol ring)
	**All have mixed serotonergic and dopaminergic activity		**All have mixed serotonergic and dopaminergic activity

2019-09-06T03:45:36Z

Background

← Revisión anterior		Revisión del 03:45 6 sep 2019
Línea 3:		Línea 3:
	[[File:MDMA.png\|thumbnail\|MDMA]]		[[File:MDMA.png\|thumbnail\|MDMA]]
	[[File:Mescaline.png\|thumbnail\|Mescaline]]		[[File:Mescaline.png\|thumbnail\|Mescaline]]
			[[File:Desoxyn (methamphetamine) 5 mg tablets.jpg\|thumb\|Desoxyn tablets – pharmaceutical methamphetamine hydrochloride]]
	*Class of xenobiotics (Substituted amphetamines) based on a common central structure (ethylamine group attached to a phenol ring)		*Class of xenobiotics (Substituted amphetamines) based on a common central structure (ethylamine group attached to a phenol ring)
	**All have mixed serotonergic and dopaminergic activity		**All have mixed serotonergic and dopaminergic activity

2019-09-06T03:42:44Z

Clinical Features

2019-09-06T03:32:35Z

Clinical Features

2019-09-06T03:29:41Z

Clinical Features

← Revisión anterior		Revisión del 03:29 6 sep 2019
Línea 23:		Línea 23:

	==Clinical Features==		==Clinical Features==
	{\| class="wikitable ~~unsortable center" style="margin: 1em auto;~~"		{\| class="wikitable"
	\|~~+ Overdose symptoms by system~~		\|-
	! scope="col" style="text-align:center"\| System		! scope="col" style="text-align:center"\| System
	! scope="col" style="width: 40%;"\| Minor or moderate overdose		! scope="col" style="width: 40%;"\| Minor or moderate overdose

2019-09-06T03:26:49Z

Clinical Features

@@ Línea 23: / Línea 23: @@
 ==Clinical Features==
-===Alpha===
+{| class="wikitable unsortable center" style="margin: 1em auto;"
-*pupils dilate
+|+ Overdose symptoms by system
-*sweat
+! scope="col" style="text-align:center"| System
-*decrease gi peristalsis
+! scope="col" style="width: 40%;"| Minor or moderate overdose
-*constrict blood vessels
+! scope="col" style="width: 50%;"| Severe overdose
+|-
-===Beta===
+! scope="row"|Cardiovascular
-*increase HR and contractility
-*dilate bronchi
+* Cardiac dysrhythmia
-*dilate muscle beds
+* Hypertension or hypotension
+|
-===Mixed===
+* Cardiogenic shock
-*delusions, paranoia, aggression, poor judgement, hallucinate, confusion
+* Cerebral hemorrhage
 ==Differential Diagnosis==

2019-09-06T02:54:28Z

Differential Diagnosis

2019-09-06T02:53:57Z

← Revisión anterior		Revisión del 02:53 6 sep 2019
Línea 1:		Línea 1:
			==Background==
	[[File:Amphetamine.png\|thumbnail\|Amphetamine]]		[[File:Amphetamine.png\|thumbnail\|Amphetamine]]
	[[File:MDMA.png\|thumbnail\|MDMA]]		[[File:MDMA.png\|thumbnail\|MDMA]]
	[[File:Mescaline.png\|thumbnail\|Mescaline]]		[[File:Mescaline.png\|thumbnail\|Mescaline]]

	~~==Background==~~
	*Class of xenobiotics (Substituted amphetamines) based on a common central structure (ethylamine group attached to a phenol ring)		*Class of xenobiotics (Substituted amphetamines) based on a common central structure (ethylamine group attached to a phenol ring)
	**All have mixed serotonergic and dopaminergic activity		**All have mixed serotonergic and dopaminergic activity
Línea 23:		Línea 22:
	*[[Hyponatremia]]		*[[Hyponatremia]]

	==~~Evaluation~~==		==Clinical Features==
	===Alpha===		===Alpha===
	*pupils dilate		*pupils dilate
Línea 40:		Línea 39:
	==Differential Diagnosis==		==Differential Diagnosis==
	{{Sympathomimetic types}}		{{Sympathomimetic types}}

			==Evaluation==

	==Management==		==Management==
	*[[Benzodiazepines]]		*[[Benzodiazepines]]

			==Disposition==

	==See Also==		==See Also==